Vol. 276, Issue 3, R901-R904, March 1999
Genetic control of renal thiazide receptor response to dietary
NaCl and hypertension
Darrell D.
Fanestil,
Duke A.
Vaughn,
Ronald H.
Hyde, and
Patricia
Blakely
Division of Nephrology/Hypertension, Department of Medicine,
University of California San Diego, La Jolla, California 92093-0623
 |
ABSTRACT |
Excess NaCl increases blood pressure in
some strains of animals but not others. An 8% NaCl diet did not change
renal thiazide receptor (TZR) density in two salt-resistant
normotensive rat strains (Wistar-Kyoto and Sprague-Dawley)
[Fanestil, D. D., D. A. Vaughn, and P. Blakely.
Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol.
42): R1241-R1245, 1997]. However, the renal response to salt
differs in normal and hypertensive kidneys [Rettig, R., N. Bandelow, O. Patschan, B. Kuttler, B. Frey, and A. Uber.
J. Hum. Hypertens. 10: 641-644,
1996]. Therefore, we examined two strains with salt-aggravated
hypertension. Renal TZR did not change when Dahl-S (salt sensitive)
animals became hypertensive with 8% dietary NaCl. In contrast, renal
TZR decreased 34%, whereas blood pressure increased further, in SHR
with 8% dietary NaCl. Blood pressure increased after
NG-nitro-L-arginine in SHR, but
renal TZR did not change, indicating the salt-induced decrease in TZR
in SHR cannot be attributed nonspecifically to elevated arterial
pressure. We conclude that the renal response to NaCl-induced increases
in blood pressure can be genetically modulated independently of the
genes that mediate either the primary hypertension or the salt
sensitivity of the hypertension. This finding may be of use in future
studies directed at identifying genotypes associated with
salt-dependent hypertension.
diuretics; distal convoluted tubule; pressure natriuresis
 |
INTRODUCTION |
SALT-SENSITIVE HYPERTENSION is influenced by genetic
background. The two rat strains developed by Dahl (8), with blood pressure that is either salt sensitive (Dahl-S) or salt resistant (Dahl-R), are a classic example in rodents. The demonstration of
salt-sensitive hypertension within substrains of spontaneously hypertensive rats (SHR) (14) may indicate that the phenomenon can be
controlled by a few genes. Considerable evidence indicates that the
kidneys have a prominent role in expressing this genetic predisposition
in both Dahl and SHR strains (7, 16). We previously observed that the
renal density of the thiazide-sensitive NaCl cotransporter [or
thiazide diuretic receptor (TZR)] was greater after 4 wk of age
in SHR than in Wistar-Kyoto (WKY) strains of animals (3). Moreover, in
that study, we found that TZR was not altered in either kidney of
animals with systemic arterial hypertension due to placement of a
constriction clip on one renal artery (3), suggesting that renal TZR
density does not respond to renal perfusion pressure. More recently, we
reported (9) that renal handling of high salt intake (8% dietary NaCl)
in normotensive strains of rats (Sprague-Dawley and WKY) did not
involve changes in renal TZR (1, 15). Moreno et al. (13) simultaneously arrived at a similar conclusion, based on their finding that salt loading (2.92% dietary NaCl) did not alter renal expression of Na-Cl
cotransporter mRNA. These observations do not exclude the possibility
that salt-sensitive hypertension involves changes in renal TZR, because
the renal response to salt differs in normal and hypertensive kidneys
(16). Therefore, the current studies were undertaken to determine if
the renal expression of salt-sensitive hypertension in rodent genetic
hypertension might involve altered TZR. We report that the response of
TZR to high dietary salt is aberrant in SHR but not in Dahl-S animals.
Thus the renal response to an NaCl-induced increase in blood pressure
is, at least in part, genetically mediated independently of the genes
that mediate either the primary hypertension or the salt sensitivity of
the hypertension.
 |
METHODS |
Male animals of the Dahl-S strain, purchased from Harlan Sprague
Dawley, and SHR from the La Jolla colony,
SHRLJ, were maintained in the
animal care facility at the University of California, San Diego (UCSD).
All protocols and procedures were approved by the UCSD Animal Subjects
Committee. Within each study, animals were of the same strain and age
and, in addition, were matched by weight into control and experimental groups.
Sodium intake was varied by offering ad libitum access to one of two
diets for 4 wk, beginning at 6 wk of age. The 1% NaCl diet (Teklad no.
TD90220) contained 0.39% sodium, 0.72% potassium, 0.66% chloride,
0.86% calcium, and 0.15% magnesium, and the 8% NaCl diet (Teklad no.
TD92023) contained 3.15% sodium, 0.71% potassium, 4.90% chloride,
0.86% calcium, and 0.14% magnesium.
The inhibitor of nitric oxide synthase,
NG-nitro-L-arginine
(L-NNA), 50 mg/l, was dissolved
in distilled water. At 15 wk of age, SHR
L-NNA animals had free access to
the drinking solution for the next 7 days, whereas age-matched control
SHR animals ingested distilled water ad libitum.
Blood pressure was measured by indwelling arterial catheters, which
were placed after 3 wk on the assigned diet (or 2 days before starting
ingestion of L-NNA) using
methodology described in detail previously (10). The reported mean
arterial pressures were obtained the day or two before death at the end
of the experimental period. Arterial blood, sampled via the indwelling
catheter on the day of death, was analyzed by ion-selective electrodes
for sodium, potassium, ionized calcium, and ionized magnesium. Plasma was analyzed for chloride using a commercially available kit (Sigma, St. Louis, MO).
Renal TZR density was determined by saturation analysis using the
binding of
[3H]metolazone to
renal membranes, as previously described in detail (4): whole kidneys
were homogenized in 10 ml ice-cold 50 mM Tris-PO4 buffer, pH 7.4, and
membranes were prepared by centrifuging them for 5 min at 600 g and centrifuging the resulting
supernatant two times at 45,000 g for
20 min. The final pellet was suspended in 10 ml buffer and
diluted to achieve a final concentration of 0.8-1.0 mg protein/ml
in the binding assay. Binding of
[3H]metolazone to each
membrane preparation was determined in duplicate at six concentrations
of [3H]metolazone
ranging from 0.313 to 10 nM. Specific binding of [3H]metolazone,
defined by displacement with
10
4 M hydroflumethiazide,
was analyzed by the Scatchard equation to calculate the density of the
binding using the EBDA program of McPherson (12). Protein
was assayed by the Bradford Coomassie blue method (6), with bovine
gamma globulin as the standard. Binding maximum is reported as
picomoles of binding sites per milligram of membrane protein.
Statistical analyses were conducted with the StatView program (Abacus
Concepts, Berkeley, CA) using Student's unpaired
t-test. Values are expressed as means ± SE.
 |
RESULTS |
Dietary NaCl in Dahl-S hypertensive rats.
Mean arterial blood pressure in the Dahl-S animals ingesting 1% NaCl
(145 ± 1.33 mmHg) was significantly
(P < 0.0001) less than that in rats
ingesting 8% NaCl (209 ± 8.93 mmHg) (Fig.
1). The plasma concentration of chloride
was significantly higher (P = 0.001)
in the 8% NaCl group (100.2 ± 0.458 mmol/l) than in the 1% NaCl
group (97.1 ± 0.474 mmol/l). The animals ingesting 8% NaCl did not
differ from the 1% NaCl animals with respect to final body weight or
the plasma concentrations of sodium, potassium, ionized calcium, and
ionized magnesium. Single kidney weight in the 8% NaCl group (0.554 ± 0.016 g/100 g body wt) was significantly (P < 0.0001) greater than in the 1%
NaCl group (0.393 ± 0.010 g/100 g body wt).
However, renal TZR density was not altered by dietary NaCl intake (1% = 1.01 ± 0.057 pmol/mg renal membrane protein, 8% = 1.09 ± 0.031 pmol/mg renal membrane protein;
P not significant) (Fig.
2).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of dietary NaCl on mean arterial blood pressure in spontaneously
hypertensive rats (SHR) and Dahl salt-sensitive (Dahl) animals. Blood
pressures were recorded intra-arterially after 4 wk on a diet
containing either 1% NaCl (n = 6, open bars) or 8% NaCl (n = 6, solid
bars). Differences between diets in both strains of animals are
statistically significant (P < 0.0001).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of dietary NaCl on renal thiazide receptor density in SHR and
Dahl salt-sensitive animals. Renal thiazide receptor (TZR) density,
expressed as pmol/mg membrane protein, was measured on renal membranes
after animals ingested for 4 wk a diet containing either 1% NaCl
(n = 6, open bars) or 8% NaCl
(n = 6, solid bars). Difference in TZR
density between the 2 groups of SHR animals is statistically
significant (P = 0.0012).
|
|
Dietary NaCl in SHR.
Mean arterial blood pressure in the
SHRLJ animals ingesting 1% NaCl
(137 ± 5.08 mmHg) was significantly
(P < 0.0001) less than in those
ingesting 8% NaCl (202 ± 9.07 mmHg) (Fig. 1). The plasma
concentration of ionized calcium was significantly lower (P < 0.02) in the 8% NaCl group
(1.08 ± 0.025 mmol/l) than in the 1% NaCl group (1.16 ± 0.013 mmol/l). The animals ingesting 8% NaCl did not differ from the 1%
NaCl animals with respect to final body weight or the plasma
concentrations of sodium, potassium, chloride, and ionized magnesium.
Single kidney weight in the 8% NaCl group (0.517 ± 0.018 g/100 g
body wt) was significantly (P = 0.0001) greater than in the 1% NaCl group (0.400 ± 0.007 g/100 g
body wt). In contrast, renal TZR density was decreased by increasing dietary NaCl intake (1% = 0.803 ± 0.22 pmol/mg protein, 8% = 0.531 ± 0.056 pmol/mg protein; P = 0.0012) (Fig. 2).
Response to inhibition of nitric oxide synthase in SHR.
Inhibition of nitric oxide synthase by administration of
L-NNA for 7 days increased mean
arterial blood pressure in SHR to 233 ± 3.50 mmHg
(n = 6) versus 181 ± 2.71 mmHg
(n = 7;
P < 0.0001) in the
control SHR animals. Plasma sodium and chloride concentrations were
slightly lower, whereas the plasma potassium concentration was
significantly higher in the
L-NNA group (Table
1). The 17% increase in renal TZR
associated with the increase in blood pressure produced in SHR by
L-NNA, which represented a
marginal level of statistical significance
(P = 0.0513; Table 1), contrasts with the 34% decrease in TZR associated with the increase in blood pressure
produced in SHR by the 8% NaCl diet (Fig. 2).
 |
DISCUSSION |
The renal response to ingestion of a diet containing 8% NaCl in
normotensive rats (Sprague-Dawley and WKY strains) in a prior study did
not involve a change in the renal density of TZR (9). Concurrently,
Moreno et al. (13) used different methodology to arrive at a similar
conclusion. Our current study tested for derangements in TZR in
salt-loaded, salt-sensitive hypertensive animals. These studies were
based on the knowledge that hypertensive SHR have greater renal TZR
density than do WKY (3) and the findings that the renal adjustments to
excretion of salt are abnormal in salt-sensitive hypertension (16).
Dahl-S animals developed severe hypertension (209 mmHg) with, as in
normotensive strains, no change in renal TZR density (Figs. 1 and 2).
In contrast, salt-induced hypertension of similar magnitude (202 mmHg)
in SHR was accompanied by a 34% decrease in renal TZR (Figs. 1 and 2).
Salt loading increased renal weight in both Dahl and SHR strains to a
similar extent (single kidney weights per 100 g body wt were not
significantly different between Dahl and SHR on either salt intake).
Thus the decrease in TZR density in SHR versus Dahl cannot be
attributed to differential changes in overall renal size. A decrease in
TZR of 34%, if expressed as reduced reabsorption of NaCl at its locus in the distal convoluted tubule (5, 15), would facilitate urinary
excretion of the excess dietary NaCl in SHR. Following this line of
reasoning leads to the presumption that normotensive rat strains and
the Dahl-S strain, when presented with a large dietary NaCl load,
decrease reabsorption of NaCl predominantly in nephron segments other
than the distal convoluted tubule. In this regard, it is of interest to
note that thiazide treatment 1)
prevents salt-dependent hypertension in Dahl-S animals (11, 18, 19) but
2) does not prevent salt-dependent
(4% dietary NaCl) strokes in stroke-prone SHR (17). Although studies
on the efficacy of thiazides on salt-accelerated hypertension in non-stroke-prone SHR are not available, thiazide diuretic treatment of
SHR on normal diets has not yielded consistent lowering of blood
pressure (reviewed in Ref. 2).
Blood pressure also increased markedly in SHR animals ingesting
L-NNA, an inhibitor of nitric
oxide synthase. The absolute level of mean arterial blood pressure (233 ± 3.50 mmHg) slightly exceeded that measured in SHR ingesting high
salt (202 ± 9.07, P < 0.01) in
the prior study, perhaps due to the older age of the animals used in
the L-NNA study. However, the
increase in blood pressure with
L-NNA in SHR was not accompanied
by a decrease in renal TZR. This finding of a lack of effect of
arterial pressure on renal TZR is similar to our prior finding that
renal perfusion pressure did not alter TZR in animals with two-kidney,
one-clip hypertension (3). We propose that the decrease in renal TZR found in NaCl-loaded SHR is not secondary to a nonspecific effect produced by any increase in arterial pressure.
Perspectives
The renal response of salt-resistant normotensive [Sprague-Dawley
and WKY in our prior study (9), Wistar in another study (13)] and
salt-sensitive Dahl-S rat strains to high NaCl (8% NaCl) intake does
not include a decrease in renal TZR, despite the differing effects of
the salt on blood pressure. In contrast, renal TZR in the SHR strain is
decreased 34% by NaCl-aggravated hypertension. A similar elevation of
blood pressure in SHR produced by inhibition of nitric oxide synthase
does not decrease renal TZR. These data provide evidence that renal
responses to salt loading are not uniform and are therefore under
genetic control that can be independent of renal responses to increased
renal perfusion pressure. This observation
1) indicates that caution is needed
when interpreting effects of dietary NaCl across strains of animals and
2) may be of use in future studies
directed at identifying genotypes associated with salt-dependent hypertension.
 |
ACKNOWLEDGEMENTS |
These studies were supported by National Heart, Lung, and Blood
Institute Program Project Grant PHS HL-35018 (Dr. Morton Printz, Program Director) and Training Grant HL-07261 (Dr. Darrell Fanestil, Program Director) and National Institute of Diabetes and Digestive and
Kidney Diseases Program Physician Scientist Award DK-01408 (Dr. Daniel
Steinberg, Program Director).
 |
FOOTNOTES |
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. D. Fanestil,
Division of Nephrology/Hypertension, Dept. of Medicine, Univ. of
California, San Diego, La Jolla, CA 92093-0623 (E-mail:
dfanestil{at}ucsd.edu).
Received 10 August 1998; accepted in final form 14 December 1998.
 |
REFERENCES |
1.
Bachmann, S.,
H. Velazquez,
N. Overmuller,
R. F. Reilly,
D. Moser,
and
D. H. Ellison.
Expression of the thiazide-sensitive Na-Cl cotransporter by rabbit distal convoluted tubule cells.
J. Clin. Invest.
96:
2510-2514,
1995.
2.
Barret, R. J.,
T. J. Buckenheimer,
B. A. McGuirk,
and
S. T. Kau.
Comparative cardiovascular effects of loop-acting, thiazide-type and potassium-sparing diuretics in Spontaneously Hypertensive Rats.
Methods Find. Exp. Clin. Pharmacol.
9:
67-78,
1987[Medline].
3.
Beaumont, K.,
D. A. Vaughn,
R. Casto,
M. P. Printz,
and
D. D. Fanestil.
Thiazide diuretic receptors in spontaneously hypertensive rats and 2-kidney 1-clip hypertensive rats.
Clin. Exp. Hypertens.
A12:
215-226,
1990.
4.
Beaumont, K.,
D. A. Vaughn,
and
D. D. Fanestil.
Thiazide diuretic drug receptors in rat kidney: identification with [3-H]metolazone.
Proc. Natl. Acad. Sci. USA
85:
2311-2314,
1988[Abstract/Free Full Text].
5.
Bostonjoglo, M.,
W. B. Reeves,
R. F. Reilly,
H. Velázquez,
N. Robertson,
G. Litwack,
P. Morsing,
J. Dørup,
S. Bachmann,
and
D. H. Ellison.
11
-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules.
J. Am. Soc. Nephrol.
9:
1347-1358,
1998[Abstract].
6.
Bradford, M. M.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
7.
Dahl, L. K.,
and
M. Heine.
Primary role of renal homografts in setting chronic blood pressure levels in rats.
Circ. Res.
36:
692-696,
1975[Abstract/Free Full Text].
8.
Dahl, L. K., K. D. Knudsen, and J. Iwai.
Humoral transmission of hypertension: evidence from parabiosis.
Circ. Res. 24, Suppl.:
S21-S33, 1969.
9.
Fanestil, D. D.,
D. A. Vaughn,
and
P. Blakely.
Dietary NaCl and KCl do not regulate renal density of the thiazide diuretic receptor.
Am. J. Physiol.
273 (Regulatory Integrative Comp. Physiol. 42):
R1241-R1245,
1997[Abstract/Free Full Text].
10.
Fanestil, D. D.,
D. A. Vaughn,
L. Ma,
R. H. Hyde,
and
M. P. Printz.
Thiazide diuretics normalize urinary calcium in spontaneously hypertensive male rats.
Kidney Int.
51:
1018-1021,
1997[Medline].
11.
Iwai, J., E. V. Ohanian, and L. K. Dahl.
Influence of thiazide on salt hypertension. Circ. Res.
40, Suppl. 1: I131-I134,
1977.
12.
McPherson, G. A.
A practical computer-based approach to the analysis of radioligand binding experiments.
Comput. Programs Biomed.
17:
107-114,
1983[Medline].
13.
Moreno, G.,
A. Merino,
A. Mercado,
J. P. Herrera,
J. González-Salazar,
R. Correa-Rotter,
S. C. Hebert,
and
G. Gamba.
Electroneutral Na-coupled cotransporter expression in the kidney during variations of NaCl and water metabolism.
Hypertension
31:
1002-1006,
1998[Abstract/Free Full Text].
14.
Oparil, S., Q. C. Meng, Y. F. Chen, R. H. Yang, H. K. Jin, and J. M. Wyss.
Genetic basis of NaCl-sensitive hypertension. J. Cardiovasc.
Pharmacol. 12, Suppl. 3:
S56-S69, 1988.
15.
Plotkin, M. D.,
M. R. Kaplan,
J. W. Verlander,
W.-S. Lee,
D. Brown,
E. Poch,
S. R. Gullans,
and
S. C. Hebert.
Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1, in the rat kidney.
Kidney Int.
50:
174-183,
1996[Medline].
16.
Rettig, R.,
N. Bandelow,
O. Patschan,
B. Kuttler,
B. Frey,
and
A. Uber.
The importance of the kidney in primary hypertension: insights from cross-transplantation.
J. Hum. Hypertens.
10:
641-644,
1996[Medline].
17.
Smeda, J. S.,
and
O. Tkachenko.
Effects of diuretics on stroke development in Kyoto-Wistar stroke-prone spontaneously hypertensive rats.
Clin. Sci. (Colch.)
81:
335-340,
1991[Medline].
18.
Tobian, L.,
J. Lange,
J. Iwai,
K. Hiller,
M. A. Johnson,
and
P. Goossens.
Prevention with thiazide of NaCl-induced hypertension in Dahl "S" Rats.
Hypertension
1:
316-323,
1979[Free Full Text].
19.
Uehara, Y.,
A. Numabe,
N. Hirawa,
Y. Kawabata,
H. Nagoshi,
H. Kaneko,
T. Gomi,
A. Goto,
T. Toyo-oka,
and
M. Omata.
A new adenosine subtype-1 receptor antagonist, FK-838, attenuates salt-induced hypertension in Dahl salt-sensitive rats.
Am. J. Hypertens.
8:
1189-1199,
1995[Medline].
Am J Physiol Regul Integr Compar Physiol 276(3):R901-R904
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society